What is the recommended postoperative dosing and opioid-sparing use of Journavx (suzetrigine) in adult patients receiving narcotics for moderate-to-severe pain?

Journavx (Suzetrigine) for Postoperative Pain with Narcotics

Journavx should be initiated preoperatively (100 mg on empty stomach) and continued postoperatively (50 mg every 12 hours) as part of multimodal analgesia to minimize or eliminate opioid requirements, not simply added to existing narcotic regimens. The drug enables opioid-free recovery in 76-91% of surgical patients when used as the primary analgesic with acetaminophen/ibuprofen 1, 2.

Dosing Strategy

Preoperative initiation:

• Give 100 mg Journavx on empty stomach (at least 1 hour before or 2 hours after food) before surgery
• Starting 12 hours after initial dose, administer 50 mg every 12 hours with or without food
• Continue for shortest duration needed, maximum studied duration is 14 days 3, 4

Key dosing modifications:

• Moderate hepatic impairment (Child-Pugh B): Reduce dose (specific reduction in full label)
• Severe hepatic impairment (Child-Pugh C): Avoid use 3
• Avoid grapefruit products and strong CYP3A inhibitors (contraindicated) 3

Opioid-Sparing Approach

Journavx functions as an opioid replacement, not an opioid adjunct. When used as part of multimodal therapy:

• 76-91% of patients require NO opioid rescue across various surgical procedures 1, 2
• Those requiring opioids used only 2.2-2.4 tablets on average for 1.7-2.0 days postoperatively 1, 2
• Pain control rated good/very good/excellent by 83-91% of patients 1, 2, 4

This contrasts sharply with current practice where <10-50% of similar surgical patients avoid opioids entirely 1, 2.

Integration with Guideline-Based Multimodal Analgesia

The optimal postoperative regimen combines:

1. Journavx 50 mg every 12 hours (primary analgesic)
2. Acetaminophen (scheduled dosing)
3. Ibuprofen/NSAIDs (if not contraindicated)
4. Immediate-release opioids ONLY as rescue (not scheduled)

This aligns with evidence-based guidelines recommending immediate-release opioids only when non-opioid analgesics fail to achieve functional goals 5, 6. The key difference: Journavx provides opioid-level analgesia without CNS effects, respiratory depression, or addiction potential 7, 8.

Opioid Rescue Protocol (When Needed)

If breakthrough pain occurs despite Journavx:

• Use immediate-release oral morphine 10 mg (5 mL) as first-line opioid rescue 5
• Dose based on age and renal function, not weight 5
• Avoid modified-release or transdermal opioid formulations 5, 6
• Prescribe opioids separately from non-opioids to allow independent dose adjustments 5

Critical assessment before giving opioids:

• Evaluate for surgical complications (compartment syndrome, anastomotic leak) that may cause increased pain 5
• Use functional pain assessment, not just numeric scores 5, 6
• Monitor sedation scores and respiratory rate to detect opioid-induced ventilatory impairment 5, 6

Discharge Planning

Limit opioid prescriptions aggressively:

• Maximum 5-7 days supply, typically less 5, 6
• Continue Journavx up to 14 days if needed for pain resolution 3, 4
• Provide explicit weaning instructions for all analgesics 5, 6
• Avoid automatic refills; require patient review if more opioids requested 6

Reverse analgesic ladder when tapering:

1. Wean opioids FIRST
2. Then stop NSAIDs
3. Finally stop acetaminophen 5

Safety Considerations

Journavx-specific monitoring:

• Most adverse events are mild-moderate: pruritus (2.1%), muscle spasms (1.3%), rash (1.1%) 3
• CPK elevations occur in 2.9% (asymptomatic, no treatment needed) 3
• eGFR decreases ≥25% in 2.5% (appears reversible) 3
• Significantly fewer adverse events than opioids (RR 0.81 vs hydrocodone/acetaminophen) 9

Critical advantage over opioids:

• No respiratory depression, sedation, or addiction potential 7, 8
• No CNS effects due to high NaV1.8 selectivity 4, 8
• Nausea/vomiting rates lower than opioids (9-20% vs 16-33%) 3

Clinical Pitfalls to Avoid

Do not:

• Add Journavx to scheduled opioids—this defeats the opioid-sparing purpose
• Wait until postoperative period to start—preoperative dosing is essential for optimal effect 1, 2
• Use pain scores alone to guide opioid administration—assess function and rule out complications 5, 6
• Prescribe modified-release opioids for acute postoperative pain 5, 6
• Continue opioids beyond 90 days without comprehensive pain evaluation 5

Do:

• Initiate Journavx preoperatively when possible 1, 2
• Combine with scheduled acetaminophen/NSAIDs, not just PRN 1, 2
• Reserve opioids strictly for rescue, not scheduled dosing
• Monitor for persistent opioid use at 90 days—this requires pain service referral 5

The evidence strongly supports using Journavx as the foundation of postoperative analgesia to minimize or eliminate opioid exposure, rather than simply adding it to existing narcotic regimens. This approach addresses both efficacy and the critical public health goal of reducing opioid-related morbidity and mortality 6, 7.